FDA Approval Activities for this Drug
Geodon (Ziprasidone) Capsules, Pfizer, NDA 20-825/S6 2/15/02 3/8/02
Geodon (Ziprasidone HCl) Capsules, Pfizer NDA 20-825 2/5/01 2/12/01 2/12/01 1/7/02
Geodon Indications: for the treatment of schizophrenia.
Geodon (Ziprasidone Mesylate) Injection, Pfizer, NDA 20-919 Geodon (Ziprasidone) Capsules & Injection, Pfizer, Inc. Geodon (ziprasidone HCl) Capsules, Pfizer, Labeling Revision
Geodon (ziprasidone mesylate) Injection, Pfizer, Labeling Revision Geodon (ziprasidone HCl) Capsules, Pfizer, Inc., New or Modified Indication | Geodon (ziprasidone HCl) Capsules, Pfizer, Labeling Revision | Geodon (ziprasidone mesylate) Injection, Pfizer, Labeling Revision | Geodon (ziprasidone HCL) Oral Suspension, Pfizer, Approval | Geodon (ziprasidone HCl ) Capsules, Pfizer, Labeling Revision | Geodon (ziprasidone mesylate) Injection, Pfizer, Labeling Revision | Geodon (ziprasidone HCl ) Capsules, Pfizer Inc., Labeling Revision | Geodon (ziprasidone mesylate) Injection, Pfizer Inc., Labeling Revision | Ziprasidone Hydrochloride Capsule, Lupin Pharma, Tentative Approval | GEODON (ziprasidone HCl) Capsules, Pfizer Inc., Labeling Revision | GEODON (ziprasidone mesylate) Injection, Pfizer Inc., Labeling Revision | Geodon (ziprasidone hydrochloride) Capsules, Pfizer, Inc., Labeling Revision | Geodon (ziprasidone mesylate) Injection, Pfizer, Inc., Labeling Revision | Geodon (ziprasidone hydrochloride) Capsules, Pfizer, Inc., Labeling Revision | Geodon (ziprasidone mesylate) Intramuscular Injection, Pfizer, Inc., Labeling Revision | Ziprasidone Hydrochloride Capsules, Sandoz, Inc., Tentative Approval